Navigation Links
Schering-Plough Reports Financial Results for 2009 Second Quarter
Date:7/21/2009

78 (14%) 128 152 (16%) INTRON 67 61 10% 121 116 4% PROVENTIL / ALBUTEROL 56 38 46% 110 89 24% ASMANEX 54 48 12% 103 91 14% SUBUTEX / SUBOXONE 52 62 (15%) 102 115 (12%) REMERON 50 61 (18%) 100 129 (22%) ELOCON 45 47 (4%) 87 92 (6%) CERAZETTE 46 49 (6%) 85 93 (8%) NOXAFIL 43 38 14% 82 72 15% IMPLANON 43 44 (1%) 80 82 (2%) MERCILON 33 47 (30%) 68 90 (25%) LIVIAL 39 50 (22%) 72 95 (24%) MARVELON 36 40 (9%) 68 77 (13%) ZEMURON 33 67 (51%) 65 130 (50%) FORADIL 25 25 (1%) 48 51 (4%) Other Pharmaceuticals 735 755 (3%) 1,396 1,458 (4%) ANIMAL HEALTH 677 818 (17%) 1,307 1,540 (15%) CONSUMER HEALTH CARE 381 401 (5%) 765 778 (2%) OTC 184 181 2% 416 389 7% OTC CLARITIN 108 120 (10%) 257 258 - MiraLAX 36 28 30% 73 54 36% Other OTC 40 33 22% 86 77 11% Foot Care 101 105 (4%) 174 190 (8%) Sun Care 96 115 (17%) 175 199 (12%) -- --- --- --- CONSOLIDATED GAAP NET SALES $4,647 $4,921 (6%) $9,040 $9,57
'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014  Franciscan St. Anthony ... capnography for respiratory monitoring outside the operating ... leaders in embracing state-of-the-art patient safety technology. ... are breathing and can alert medical caregivers ... the amount of carbon dioxide the patient ...
(Date:7/10/2014)... July 10, 2014 /PRNewswire-iReach/ -- Tute Genomics, ... today announced an agreement with Lineagen, Inc., ... Lineagen,s NextStep Dx PLUS.  Lineagen, focused ... neurological disorders, currently offers FirstStep Dx ... service used by healthcare providers as a ...
(Date:7/10/2014)... 15, 2014 -- According to the International Atomic ... security comes from terrorists acquiring sufficient quantities of ... a crude nuclear explosive device. The IAEA also ... have involved gram-level quantities, which can be challenging ... to a new study appearing this week in ...
(Date:7/10/2014)... the journal PNAS (Proceedings of the National Academy ... and sleep deprivation have a significant effect on our ... the best time of day to test for diseases ... medicines effectively. , Researchers from the University of Surrey ... links between sleep deprivation, body clock disruption and metabolism, ...
Breaking Biology Technology:Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4Sensitive detection method may help impede illicit nuclear trafficking 2Time of day crucial to accurately test for diseases, new research finds 2
... April 5, 2011 Embryo Donation International ... facilities in the United States, officially opened today to ... globe desiring to build a family.     ... mission is to reduce the number of frozen ...
... YORK, April 5, 2011 Reportlinker.com announces that ... its catalogue: DNA Sequencing - ... http://www.reportlinker.com/p0203540/DNA-Sequencing---technologiesmarkets-and-companies.html This report briefly ... sequencing technologies, and their applications. Current large and ...
... PITTSBURGH, April 5, 2011 Mylan Inc. (Nasdaq: ... subsidiary Bioniche Pharma has launched Octreotide Acetate Injection ... Novartis, Sandostatin®, a treatment for a rare hormonal ... used to suppress or inhibit severe diarrhea associated ...
Cached Biology Technology:A New Company Is Born - Embryo Donation International 2Reportlinker Adds DNA Sequencing - Technologies, Markets and Companies 2Mylan Launches Generic Version of Sandostatin® 2
(Date:7/11/2014)... Salk Institute for Biological Studies, BGI, and other ... and reliability of the existing targeted gene correction ... which could significantly increased gene-correction efficiency in human ... online in Cell Stell Cell provides ... therapy. , The combination of stem cells and ...
(Date:7/11/2014)... Researchers have pioneered a revolutionary new way ... called Virtual Finger, allows scientists to move through ... synapses using the flat surface of their computer ... studies orders of magnitude more efficient, saving time, ... many areas of experimental biology. The software and ...
(Date:7/11/2014)... the normal circumstances, astrocytes participate in normal ... and exhibit therapeutic and repairing effects on ... have found that nerve cells differentiated from ... reduced viability, which produces influences on subsequent ... General Hospital, Hebei United University, China demonstrated ...
Breaking Biology News(10 mins):A new genome editing method brings the possibility of gene therapies closer to reality 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... Scientists have known for some time that throwing off ... In fact, workers whose sleep-wake cycles are disrupted by ... such as diabetes, obesity and cancer. Researchers at ... a possible molecular link between circadian rhythm disturbances and ...
... Aug. 1 by scientists at Cold Spring Harbor Laboratory ... Meier-Gorlin syndrome (MGS) with specific cellular dysfunctions that are ... of dwarfism, small brain size, and other manifestations of ... Although only 53 cases of Meier-Gorlin syndrome have been ...
... team of researchers, including scientists from Wits University, have substantially ... of modern culture, all thanks to the San people of ... from South Africa, France, Italy, Norway, the USA and Britain, ... journal, Proceedings of the National Academy of Sciences , ...
Cached Biology News:Scientists discover molecular link between circadian clock disturbances and inflammatory diseases 2Scientists discover molecular link between circadian clock disturbances and inflammatory diseases 3Protein involved in DNA replication, centrosome regulation linked to dwarfism, small brain size 2Protein involved in DNA replication, centrosome regulation linked to dwarfism, small brain size 3Protein involved in DNA replication, centrosome regulation linked to dwarfism, small brain size 4Modern culture 44,000 years ago 2Modern culture 44,000 years ago 3
Mouse monoclonal antibody raised against a partial recombinant PASK. NCBI Entrez Gene ID = PASK...
Agarose II (Low Melt)...
...
... I can be used in intracellular staining ... cells and to serve as an antibody ... cell permeabilization is a reversible process, it ... the presence of saponin during intracellular staining. ...
Biology Products: